实用老年医学 ›› 2021, Vol. 35 ›› Issue (4): 386-389.doi: 10.3969/j.issn.1003-9198.2021.04.017

• 临床研究 • 上一篇    下一篇

高龄终末期肾衰竭病人不同治疗方式的临床疗效观察

赵君, 张志勇, 李明旭, 于海, 李楠, 玄方, 赵艺欣   

  1. 100048 北京市,中国人民解放军总医院第六医学中心肾脏病科
  • 收稿日期:2020-05-20 发布日期:2021-04-25
  • 通讯作者: 张志勇,Email:zhangzhiyong2005@tom.com

Clinical efficacy of different treatment methods in elderly patients with end-stage renal failure

ZHAO Jun, ZHANG Zhi-yong, LI Ming-xu, YU Hai, LI Nan, XUAN Fang, ZHAO Yi-xin   

  1. Department of Nephrology, Sixth Medical Center, Chinese PLA General Hospital, Beijing 100048, China
  • Received:2020-05-20 Published:2021-04-25

摘要: 目的 比较高龄(≥80岁)终末期肾衰竭病人采取不同治疗方式的临床疗效,探讨适合高龄终末期肾衰竭病人的治疗方式。方法 收集本院5年间诊治的高龄终末期肾衰竭病人59例,其中18例采取单纯药物治疗,22例行常规血液透析(HD)治疗,19例以保留残余肾功能为目的进行低剂量透析治疗,比较3组间生命体征、血液生化指标、预后等指标的差异。结果 治疗初期(6个月),常规透析剂量组和低透析剂量组在贫血、酸中毒、心功能的纠正和部分生活质量的改善方面优于单纯药物组(P<0.05),常规透析剂量组和低透析剂量组在残余尿量方面差异有统计学意义(P<0.05)。在治疗后期(24个月),低透析剂量组在残余尿量、生活质量方面优于单纯药物组和常规透析剂量组(P<0.05)。多脏器功能衰竭发生率及生存率3组间差异无统计学意义(P>0.05)。结论 高龄终末期肾衰竭病人选择HD治疗应尽量保留残余肾功能,这有利于提高病人的生活质量。

关键词: 高龄, 终末期肾衰竭, 血液透析, 生活质量, 生存率, 残余肾功能

Abstract: Objective To explore the appropriate treatment methods for the elderly patients with end-stage renal failure. Methods A total of 59 elderly patients with end-stage renal failure diagnosed and treated in our hospital were collected. Eighteen cases were treated with medication alone, and 22 cases were treated with conventional hemodialysis, and 19 cases were treated with low-dose dialysis for the purpose of preserving residual renal function. The vital signs, blood biochemical indicators, prognosis and other indicators among the 3 groups were compared. Results At the initial stage of treatment (6 months), the conventional dialysis group and the low-dose dialysis group showed better effect than the drug group in terms of anemia, acidosis, heart failure correction and quality of life (P<0. 05). There were significiant differences in residual urine volume between the conventional dialysis group and the low-dose dialysis group (P<0. 05). In the later period of treatment (24 months), the low-dose dialysis group showed better effects than the drug group and the conventional dialysis group in terms of residual urine volume and quality of life (P<0. 05). The incidence rate of multiple organ dysfunction syndrome (MODS) and the survival rate showed with no significantly statistic differences among the three groups. Conclusions The elderly patients with end-stage renal failure choose hemodialysis treatment should preserve the residual renal function as much as possible, which is conductive to impove the quality of life of patients.

Key words: advanced age, end-stage renal failure, hemodialysis, quality of life, survival rate, residual renal function

中图分类号: